Stock Events

Stock Events

Stella Diagnostics 

$0.010000
2
+$0.00+0%Friday 20:00

Statistics

Day High
0.006
Day Low
0.006
52W High
0.028
52W Low
0.0051
Volume
1
Avg. Volume
15
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap23.86B
Guardant Health, Inc. specializes in liquid biopsies and cancer diagnostics, competing in the same space as Stella Diagnostics with a focus on innovative cancer detection methods.
Fulgent Genetics
FLGT
Mkt Cap591.03M
Fulgent Genetics, Inc. focuses on genetic testing and diagnostics, competing with Stella Diagnostics in the genetic and molecular diagnostics market.
Myriad Genetics
MYGN
Mkt Cap434.25M
Myriad Genetics, Inc. specializes in molecular diagnostic tests, including for cancer, competing in the same diagnostic space as Stella Diagnostics.
Qiagen NV
QGEN
Mkt Cap9.24B
Qiagen N.V. provides sample and assay technologies for molecular diagnostics, competing with Stella Diagnostics in the market for diagnostic solutions.
Quest Diagnostics
DGX
Mkt Cap25.75B
Quest Diagnostics Incorporated offers diagnostic testing services, competing with Stella Diagnostics in the broader diagnostic and healthcare service market.
Labcorp
LH
Mkt Cap22.7B
Laboratory Corporation of America Holdings operates in the same clinical laboratory and diagnostics industry as Stella Diagnostics, offering a range of testing services.
Thermo Fisher Scientific
TMO
Mkt Cap242.11B
Thermo Fisher Scientific Inc. provides analytical instruments and reagents, competing indirectly with Stella Diagnostics by offering tools and technologies for diagnostics research and development.

About

Stella Diagnostics Inc. is a molecular diagnostics firm primarily focused on advancing patient care strategies for individuals afflicted with severe esophageal disorders. The company's specialized clinical tests furnish physicians with crucial information regarding the molecular makeup of a patient's tissue, enabling them to ascertain if the disease is static, deteriorating, or undergoing malignant transformation. Additionally, Stella Diagnostics is engaged in the development of innovative diagnostic tools intended to provide healthcare professionals with enhanced molecular insights compared to conventional screening methods. The organization rebranded from its previous identity, JMP Properties, Inc., to Stella Diagnostics, Inc. in April 2021 and is based in Salt Lake City, Utah.
Show More
CEO
David Seaburg
Employees
2
Country
United States
ISIN
US85853Y1047

Listings

OTC Link
US
SLDX

0 Comments

Share your thoughts

FAQs

What is Stella Diagnostics stock price today?▼
The current price of SLDX is $0.01 USD — it has increased by +0% in the past 24 hours. Watch Stella Diagnostics stock price performance more closely on the chart.
What is Stella Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Stella Diagnostics stocks are traded under the ticker SLDX.
Is Stella Diagnostics stock price growing?▼
SLDX stock has fallen by -0% compared to the previous week, the month change is a +0% rise, over the last year Stella Diagnostics has showed a -33.33% decrease.
How many employees does Stella Diagnostics have?▼
As of November 1, 2026, the company has 2 employees.
In which sector is Stella Diagnostics located?▼
Stella Diagnostics operates in the Health & Wellness sector.
When did Stella Diagnostics complete a stock split?▼
The last stock split for Stella Diagnostics was on March 8, 2019 with a ratio of 1:50000.
Where is Stella Diagnostics headquartered?▼
Stella Diagnostics is headquartered in Salt Lake City, United States.